共有 50 笔近期内部人交易记录记录,涉及 OncoSec Medical Incorporated (ONCS), 包括 28 笔买入 和 17 笔卖出. 内部人买入总额为 $10.66M 内部人卖出总额为 $1.2M.
近期活跃的重要内部人包括 Delaversano Robert J, Foster Spahr Stephany, Arch Robert H.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ONCS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2023-02-09 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
40 |
$1.37 |
$54.80 |
1,008 |
| 2022-11-04 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
283 |
$0.37 |
$104.71 |
22,975 |
| 2022-10-07 |
Foster Spahr Stephany |
Director |
未知 |
- |
- |
- |
- |
| 2022-10-07 |
Foster Spahr Stephany |
Director |
限制性股票授予 (RSU) |
50,000 |
- |
- |
50,000 |
| 2022-08-05 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
284 |
$0.71 |
$201.64 |
23,258 |
| 2022-05-06 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
274 |
$0.83 |
$227.42 |
23,542 |
| 2022-05-02 |
Arch Robert H. |
Officer |
未知 |
- |
- |
- |
- |
| 2022-05-02 |
Arch Robert H. |
President and CEO |
限制性股票授予 (RSU) |
700,000 |
- |
- |
700,000 |
| 2022-02-17 |
Chi George |
Officer |
未知 |
- |
- |
- |
- |
| 2022-02-09 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
409 |
$0.88 |
$359.92 |
23,816 |
| 2021-12-17 |
Shi Lin |
Director |
未知 |
- |
- |
- |
- |
| 2021-11-01 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
343 |
$1.75 |
$600.25 |
24,225 |
| 2021-08-23 |
Zhao Yuhang |
Director |
知情买入 |
4,000 |
$1.88 |
$7.52K |
12,000 |
| 2021-08-23 |
Dalesandro Margaret |
Director |
知情买入 |
20,000 |
$1.89 |
$37.8K |
20,000 |
| 2021-08-20 |
Zhao Yuhang |
Director |
知情买入 |
8,000 |
$1.94 |
$15.52K |
8,000 |
| 2021-08-02 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
412 |
$2.18 |
$898.16 |
24,568 |
| 2021-06-28 |
Dalesandro Margaret |
Director |
限制性股票授予 (RSU) |
37,500 |
$3.16 |
$118.5K |
37,500 |
| 2021-06-28 |
Demesa James M |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Ward Robert |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Leuthner Brian A |
Interim CEO |
限制性股票授予 (RSU) |
33,000 |
$3.16 |
$104.28K |
33,000 |
| 2021-06-28 |
Delaversano Robert J |
Vice President, Finance |
限制性股票授予 (RSU) |
35,000 |
$3.16 |
$110.6K |
35,000 |
| 2021-06-28 |
Kim Joon |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Zhao Yuhang |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Smith Kevin Raymond Merrill |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Zhou Chao |
10 Percent Owner |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-06-28 |
Lyerly Herbert Kim |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.16 |
$79K |
25,000 |
| 2021-05-03 |
Delaversano Robert J |
VP, Finance |
知情卖出 |
453 |
$4.86 |
$2.2K |
24,980 |
| 2021-04-30 |
O'connor Daniel J. |
CEO and President |
知情卖出 |
3,172 |
$4.86 |
$15.42K |
96,097 |
| 2021-04-16 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
知情买入 |
281,968 |
$3.45 |
$972.79K |
3,359,607 |
| 2021-02-18 |
Alpha Holdings, Inc. |
Director |
实值期权行权 |
368,250 |
$3.45 |
$1.27M |
- |
| 2021-02-02 |
Leuthner Brian A |
Officer |
未知 |
- |
- |
- |
- |
| 2021-02-02 |
Leuthner Brian A |
Chief Operating Officer |
限制性股票授予 (RSU) |
150,000 |
$7.45 |
$1.12M |
150,000 |
| 2021-02-01 |
O'connor Daniel J. |
CEO and President |
知情卖出 |
3,413 |
$7.71 |
$26.31K |
99,269 |
| 2021-02-01 |
Delaversano Robert J |
Principal Accounting Officer |
限制性股票授予 (RSU) |
8,750 |
- |
- |
25,433 |
| 2021-01-25 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
知情买入 |
677,839 |
$5.45 |
$3.69M |
3,077,639 |
| 2020-11-20 |
Alpha Holdings, Inc. |
Director |
知情卖出 |
80,000 |
$4.92 |
$393.87K |
1,350,001 |
| 2020-11-19 |
Alpha Holdings, Inc. |
Director |
知情卖出 |
50,000 |
$5.10 |
$255.23K |
1,430,001 |
| 2020-11-18 |
Alpha Holdings, Inc. |
Director |
知情卖出 |
10,999 |
$5.24 |
$57.65K |
1,480,001 |
| 2020-11-17 |
Alpha Holdings, Inc. |
Director |
知情卖出 |
40,000 |
$5.17 |
$206.74K |
1,531,000 |
| 2020-11-16 |
Alpha Holdings, Inc. |
Director |
知情卖出 |
40,000 |
$5.41 |
$216.33K |
1,571,000 |
| 2020-11-02 |
O'connor Daniel J. |
CEO and President |
知情卖出 |
3,280 |
$3.79 |
$12.43K |
102,682 |
| 2020-09-14 |
Dalesandro Margaret |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-09-14 |
Demesa James M |
Director |
限制性股票授予 (RSU) |
50,000 |
$3.43 |
$171.5K |
50,000 |
| 2020-09-14 |
Ward Robert |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-09-14 |
Lyerly Herbert Kim |
Director |
限制性股票授予 (RSU) |
25,000 |
$3.43 |
$85.75K |
25,000 |
| 2020-08-24 |
O'connor Daniel J. |
CEO and President |
限制性股票授予 (RSU) |
152,000 |
$3.82 |
$580.64K |
152,000 |
| 2020-08-24 |
Delaversano Robert J |
Principal Accounting Officer |
限制性股票授予 (RSU) |
27,000 |
$3.82 |
$103.14K |
27,000 |
| 2020-08-24 |
Foerter Kellie Malloy |
Chief Operating Officer |
限制性股票授予 (RSU) |
65,000 |
$3.82 |
$248.3K |
65,000 |
| 2020-08-19 |
China Grand Pharmaceutical & Healthcare Holdings Ltd |
10 Percent Owner |
知情买入 |
399,800 |
$3.25 |
$1.3M |
2,399,800 |
| 2020-07-31 |
O'connor Daniel J. |
CEO and President |
知情卖出 |
3,133 |
$4.20 |
$13.16K |
105,962 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期